Robert Grant is an MD/PhD Clinician Investigator at the Princess Margaret Cancer Centre, specializing in the treatment of biliary and pancreatic cancer, who is also affiliated with the Institute for Medical Science at the University of Toronto, ICES, and the Ontario Institute for Cancer Research. His research focuses on applying artificial intelligence to clinical and genomic data to improve outcomes for people with cancer. He is currently the Principal Investigator of AIM2REDUCE and Co-Leads the Legresley Biliary Registry and the PanCuRx Translational Research Initiative.